These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28544162)

  • 1. Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship.
    Shrivastava N; Naim MJ; Alam MJ; Nawaz F; Ahmed S; Alam O
    Arch Pharm (Weinheim); 2017 Jun; 350(6):. PubMed ID: 28544162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.
    Jeon KH; Yu HB; Kwak SY; Kwon Y; Na Y
    Bioorg Med Chem; 2016 Nov; 24(22):5921-5928. PubMed ID: 27707625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era.
    Yadav S; Narasimhan B; Kaur H
    Anticancer Agents Med Chem; 2016; 16(11):1403-1425. PubMed ID: 26526461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of 2-phenylnaphthalenoids and 2-phenylbenzofuranoids as DNA topoisomerase inhibitors and antitumor agents.
    Hao H; Chen W; Zhu J; Lu C; Shen Y
    Eur J Med Chem; 2015 Sep; 102():277-87. PubMed ID: 26291037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor Effect of Pomolic Acid in Acute Myeloid Leukemia Cells Involves Cell Death, Decreased Cell Growth and Topoisomerases Inhibition.
    Pereira MXG; Hammes ASO; Vasconcelos FC; Pozzo AR; Pereira TH; Caffarena ER; Gattass CR; Maia RC
    Anticancer Agents Med Chem; 2018; 18(10):1457-1468. PubMed ID: 29651965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Biological Evaluation of Structurally Diverse Benzimidazole Scaffolds as Potential Chemotherapeutic Agents.
    Barasa L; Vemana HP; Surubhotla N; Ha SS; Kong J; Yong A; Croft JL; Dukhande VV; Yoganathan S
    Anticancer Agents Med Chem; 2020; 20(3):301-314. PubMed ID: 31746304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights for the use of quercetin analogs in cancer treatment.
    Iacopetta D; Grande F; Caruso A; Mordocco RA; Plutino MR; Scrivano L; Ceramella J; Muià N; Saturnino C; Puoci F; Rosano C; Sinicropi MS
    Future Med Chem; 2017 Nov; 9(17):2011-2028. PubMed ID: 29076772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents.
    Kathiravan MK; Kale AN; Nilewar S
    Mini Rev Med Chem; 2016; 16(15):1219-1229. PubMed ID: 27549098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
    Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
    Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking simulation, synthesis and 3D pharmacophore studies of novel 2-substituted-5-nitro-benzimidazole derivatives as anticancer agents targeting VEGFR-2 and c-Met.
    Ibrahim HA; Awadallah FM; Refaat HM; Amin KM
    Bioorg Chem; 2018 Apr; 77():457-470. PubMed ID: 29453077
    [No Abstract]   [Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy.
    Yuan Z; Chen S; Chen C; Chen J; Chen C; Dai Q; Gao C; Jiang Y
    Eur J Med Chem; 2017 Sep; 138():1135-1146. PubMed ID: 28763648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid imidazole (benzimidazole)/pyridine (quinoline) derivatives and evaluation of their anticancer and antimycobacterial activity.
    Mantu D; Antoci V; Moldoveanu C; Zbancioc G; Mangalagiu II
    J Enzyme Inhib Med Chem; 2016; 31(sup2):96-103. PubMed ID: 27250919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay.
    de Oliveira JF; Lima TS; Vendramini-Costa DB; de Lacerda Pedrosa SCB; Lafayette EA; da Silva RMF; de Almeida SMV; de Moura RO; Ruiz ALTG; de Carvalho JE; de Lima MDCA
    Eur J Med Chem; 2017 Aug; 136():305-314. PubMed ID: 28505535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solvent-free synthesis and anticancer activity evaluation of benzimidazole and perimidine derivatives.
    Kumar A; Banerjee S; Roy P; Sondhi SM; Sharma A
    Mol Divers; 2018 Feb; 22(1):113-127. PubMed ID: 29143160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
    Singh M; Tandon V
    Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA topoisomerases as molecular targets for anticancer drugs.
    Buzun K; Bielawska A; Bielawski K; Gornowicz A
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1781-1799. PubMed ID: 32975138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents.
    Chen CL; Liu FL; Lee CC; Chen TC; Chang WW; Guh JH; Ahmed Ali AA; Chang DM; Huang HS
    Eur J Med Chem; 2014 Nov; 87():30-8. PubMed ID: 25240093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antitumor activity and SAR study of novel [1,2,4]triazino[4,5-a]benzimidazole derivatives.
    El-Nassan HB
    Eur J Med Chem; 2012 Jul; 53():22-7. PubMed ID: 22542105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11-Substituted Benzo[c]phenanthridines: New Structures and Insight into Their Mode of Antiproliferative Action.
    Clement B; Girreser U; Steinhauer TN; Meier C; Marko D; Aichinger G; Kaltefleiter I; Stenzel L; Heber D; Weide M; Wolschendorf U; Zebothsen I; Zur Nieden D
    ChemMedChem; 2016 Oct; 11(19):2155-2170. PubMed ID: 27546098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new phenolic series of indenopyridinone as topoisomerase inhibitors: Design, synthesis, and structure-activity relationships.
    Shrestha A; Park S; Jang HJ; Katila P; Shrestha R; Kwon Y; Lee ES
    Bioorg Med Chem; 2018 Oct; 26(18):5212-5223. PubMed ID: 30262132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.